posted
Cord Blood America CEO Discusses Reasons for New, Large Stem Cell Laboratory Thursday 07/30/2009 5:00 AM ET - Pr Newswire
Related Companies Symbol Last %Chg CBAI 0.0032 6.67%
As of 3:10 PM ET 8/5/09 Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Matthew Schissler, founder and CEO, in an interview with analyst Francis Gaskins, emphasized that the Company's new stem cell laboratory in Las Vegas will allow it to significantly diversify its revenue stream.
Cord Blood America recently announced it is opening a state-of-the-art laboratory, one of the largest in the U.S., for the storage of multiple stem cell products, including adipose tissue, peripheral blood stem cells and umbilical cord blood stem cells. "The lab will allow Cord Blood to store new sources of stem cells, greatly increasing our competitive advantage," Mr. Schissler said in the interview. "We believe that more and more uses for stem cells in treating diseases are going to be found, making their storage even more valuable."
Cord Blood America's CEO also emphasized that the new lab reduces the cost of storing stem cells for the company and allows it to begin a research and development program and to seek government and other grants.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick*eandecommunications.com
SOURCE Cord Blood America, Inc.
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck!
IP: Logged |
posted
Cord Blood America Retires $2.53M Obligation Wednesday 08/05/2009 5:00 AM ET - Pr Newswire
Related Companies Symbol Last %Chg CBAI 0.0032 6.67%
As of 3:13 PM ET 8/5/09 Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it has retired $2.53M of long-term debt.
"The two notes signed in February and March of 2007 respectively, between CBAI and the Shelter Island Opportunity Fund (SIOF), have been retired as of August 3, 2009. With this debt retirement, CBAI has only the put option agreement obligation with SIOF remaining on its balance sheet. Cord Blood America regards this as a key milestone on its path to being able to operate debt free," said Matthew Schissler, Cord Blood America Founder and CEO. "Shelter Island provided us with the capital to purchase CorCell, which is the first licensed family cord blood banking company in the United States. Using their financing allowed us to establish CBAI as one of the largest domestic stem cell storage companies. Our obligation was to pay the notes in full before the February 28, 2010 maturity date. We are happy to have met the obligation and have saved a significant amount of interest payments because of early payoff."
"We have repeatedly said that decreasing debt would be one of our significant items to focus on in 2009," said Mr. Schissler. "Eliminating debt makes our financial balance sheet stronger and makes Cord Blood America a better investment. We are very pleased with this development."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick*eandecommunications.com
Recent Headlines Cord Blood America Retires $2.53M Obligation Wednesday 08/05/2009 5:00 AM ET - Pr Newswire Cord Blood America CEO Discusses Reasons for New, Large Stem Cell Laboratory Thursday 07/30/2009 5:00 AM ET - Pr Newswire Cord Blood America CEO Discusses New State-of-the-Art State Laboratory in Fox News Television Interview Wednesday 07/22/2009 12:59 PM ET - Pr Newswire Skymark Research Initiates Complimentary Research Coverage On Cord Blood America, Inc. Wednesday 07/22/2009 9:30 AM ET - Globenewswire Cord Blood America Highlights Significant 2009 Progress Monday 07/20/2009 5:00 AM ET - Pr Newswire 7/10, MoneyTV with Donald Baillargeon Friday 07/10/2009 5:00 AM ET - Market Wire Cord Blood America Hires Management Team for Its New Stem Cell Laboratory Friday 07/10/2009 4:00 AM ET - Pr Newswire Cord Blood America Leases Las Vegas Building for Its Own Stem Cell Laboratory Thursday 07/09/2009 5:00 AM ET - Pr Newswire Cord Blood America Secures $7.5 Million Investment Tuesday 07/07/2009 2:59 PM ET - Investrend Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock Tuesday 07/07/2009 5:00 AM ET - Pr Newswire
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck!
IP: Logged |
posted
Ticker, I knew you'd come thru 4 me. Thanks, I'm watching this one!! U missed the fun run w/ ldsr today. I was a blast to watch many make some money!!
IP: Logged |
LOS ANGELES, CA -- (Marketwire) -- 08/07/09 -- Bioterrorism detection, stem cell storage lab, "Dead of Night" movie and mortgage advice; this week on MoneyTV, hosted by anchor Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs, providing insights into their operations and outlooks for their futures.
Free information packages from the featured companies can be requested by sending an email to info*moneytv.net.
The television program can also be viewed online immediately at www.moneytv.net.
Featured companies on this week's program include:
Universal Detection Technology (OTCBB: UNDT) CEO Jacques Tizabi discussed his company's bioterrorism detection technology, marketing efforts for the 2010 World Cup and the recent awarding of a patent.
Cord Blood America, Inc. (OTCBB: CBAI) CEO Matthew Schissler talked about the company's new laboratory in Las Vegas, scheduled to go online in October.
Platinum Studios, Inc. (OTCBB: PDOS) COO Brian Altounian relayed his enthusiasm after viewing the director's cut of "Dead of Night."
Nexia Holdings, Inc. (PINKSHEETS: NXHD) CEO Richard Surber announced record revenues for the company's Landis Salons.
Seamless Corporation Spokesperson James Farinella talked about a meeting he had with Dr. Gadget and the company's alliance with him.
The Mortgage Minute Guy Roger Schlesinger explained time was short to take advantage of the $8,000 tax credit for home buyers.
Viewers of MoneyTV can receive free information in the mail about featured companies by calling the toll-free phone number on their TV screen. The weekly television program debuted in 1996 and is broadcast nationally in the USA to 70 million U.S. homes on Saturdays at 11:00 AM ET, Sundays at 8:30 AM PT, 8:30 AM ET, 9:30 AM ET, 3:30 PM ET and Mondays at 6:30 PM ET.
MoneyTV is also broadcast to 48 million TV homes in Western Europe, the 21 Caribbean Territories on CaribVision Network and in Asia on Familyland Network.
A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net
MoneyTV television program, Copyright MMIX all rights reserved. MoneyTV does not provide an analysis of companies' financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks.
Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst.
MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,500.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by Donald Baillargeon, the producers, publisher or parent company of MoneyTV.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact:
Donald Baillargeon
Executive Producer
MoneyTV
949 388 5267
Info*moneytv.net
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck!
IP: Logged |
Cord Blood America New Las Vegas Stem Cell Laboratory Scheduled for Opening in 4th Quarter 2009
SANTA MONICA, Calif. and LAS VEGAS, Aug. 11 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , one of the largest umbilical cord blood stem cell preservation companies (http://www.cordblood-america.com/ ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that work has begun at its new, 17,000 square foot facility in Las Vegas for conversion into a state-of-the-art laboratory for the storage of stem cells and for research and development.
"Our target for having a cord blood processing lab in operation, a testing lab, and a cryogenic storage area is the fourth quarter of 2009. This will complete Phase One of the construction. Currently architectural plans are completed and needed demolition of parts of the interior building is underway," said Matthew Schissler, CEO and founder of Cord Blood America.
"Phase Two will involve building out of the largest cryogenic facilities in the country, as well as a research laboratory, additional processing labs and a clean room," Mr. Schissler said. "Completion is expected in 2010."
Cord Blood America recently announced it is opening a state-of-the-art laboratory for the storage of multiple stem cell products, including umbilical cord blood stem cells, in Las Vegas. The lab will be used to process and store umbilical cord blood stem cells, to store other forms of stem cells such as stem cells from the peripheral blood stream and adipose tissues, and for research and product development.
Dr. Geoffrey John O'Neill, author or co-author of more than 75 publications about stem cells, and former Laboratory and Scientific/Medical Director for Cryo-Cell International Inc. in Florida, will serve as Laboratory Director. Brian Pockett, with more than 30 years professional experience in operations, business development, marketing, sales and financial and grant development, including serving as a consultant on global distribution, product development, commercialization, investment and intellectual properties for some of the largest companies in the U.S., is Vice President of Laboratory Operations.
About Cord Blood America
Cord Blood America (OTC:CBAI) (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as ``anticipate,' ``believe,' ``expect,' ``future,' ``intend,' ``plan,' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT: Paul Knopick E & E Communications 949/707-5365
DATASOURCE: Cord Blood America, Inc.
CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,
posted
Posted by: EDWARD STEVENSON Date: Wednesday, December 30, 2009 4:59:49 PM In reply to: bigarow who wrote msg# 21067 Post # of 21975
CBAI: Technical Analysis Video [12.30.09]
Wednesday’s trading session began on a low note – literally – as the price tested the breakout level from the prior session. A dramatic change occurred as the ‘bulls’ or ‘longs’ propelled the price back above the open, and eventually towards a nice gain on the session – fueled by above average volume continuing to frequent the market. My thoughts and analysis, in video format, follow.
Shares of Cord Blood America, Inc. declined in a modest fashion after an overextended market prevailed. To-date retracements in the market have played a very natural role, only to be succeeded by further rallies in price. Friday’s trading session was an ideal example of the importance of technical analysis, and it’s application to CBAI’s market. Analysis, in video format, follows.
posted
schedule for new facility released. expect news in the coming week. support around 0.015 built. next big resistance at .02 look for this one to really gain in the coming weeks
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Big Grin]](biggrin.gif)
![[Were Down]](graemlins/weredown.gif)
![[Good Luck]](graemlins/goodluck.gif)
